Skip to main content

Table 3 Estimated Percentage of BMS Patients Likely to Receive DES by Year Following DES Approval

From: Changing treatment patterns for coronary artery revascularization in Canada: the projected impact of drug eluting stents

  Mean Median Min Max # of Panel Members Responding
% of Bare Metal Stent Patients Receiving DES, 1st Year Following Approval
all patients 24.0% 22.5% 5.1% 65.0% 10
all patients with single-vessel 18.8% 12.6% 5.0% 50.0% 8
all patients with multi-vessel 32.9% 25.0% 5.0% 80.0% 6
% of Bare Metal Stent Patients Receiving DES, 2nd Year Following Approval
all patients 36.6% 40.0% 10.2% 65.0% 10
all patients with single-vessel 28.4% 30.4% 10.0% 50.0% 9
all patients with multi-vessel 43.9% 40.0% 5.1% 100.0% 8
% of Bare Metal Stent Patients Receiving DES, 3rd Year Following Approval
all patients 57.1% 60.0% 20.5% 80.0% 10
all patients with single-vessel 53.5% 60.0% 20.0% 80.9% 9
all patients with multi-vessel 61.2% 65.0% 10.3% 100.0% 8
% of Bare Metal Stent Patients Receiving DES, 4th Year Following Approval
all patients 76.7% 80.0% 50.8% 91.0% 10
all patients with single-vessel 69.6% 80.0% 30.0% 91.0% 9
all patients with multi-vessel 85.0% 80.0% 80.0% 100.0% 7
% of Bare Metal Stent Patients Receiving DES, 5th Year Following Approval
all patients 85.0% 90.0% 49.0% 100.0% 10
all patients with single-vessel 81.7% 90.0% 49.0% 100.0% 9
all patients with multi-vessel 88.4% 90.0% 60.0% 100.0% 8